Cite
HARVARD Citation
Judson, I. et al. (2019). Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial. Lancet oncology. 20 (7), pp. 1023-1034. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Judson, I. et al. (2019). Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial. Lancet oncology. 20 (7), pp. 1023-1034. [Online].